Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Nov 3, 2016, after the close
10-Q filed Nov 3, 2016, 34 days after period end · 0001171843-16-012917
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $25.01M | $25.73M | $25.45M | $25.14M |
| Net Income | -$1.64M | -$847.00K | $633.00K | -$984.00K |
| EPS Diluted | -$0.05 |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.02 |
| $0.02 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
